Stereotactic ablative radiation therapy versus conventionally fractionated radiation therapy for stage I small cell lung cancer
Vivek Verma, Shaakir Hasan, Rodney E. Wegner et al. · Radiotherapy and Oncology · 2018
Cited by 20 works. doi:10.1016/j.radonc.2018.12.006
Authors
References
- The National Comprehensive Cancer Network
- MatchIt : Nonparametric Preprocessing for Parametric Causal Inference
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studies
- The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States
- A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
- MEDICAL RESEARCH COUNCIL COMPARATIVE TRIAL OF SURGERY AND RADIOTHERAPY FOR PRIMARY TREATMENT OF SMALL-CELLED OR OAT-CELLED CARCINOMA OF BRONCHUS
- Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
- Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
- A Prospective Randomized Trial to Determine the Benefit of Surgical Resection of Residual Disease Following Response of Small Cell Lung Cancer to Combination Chemotherapy
- SPACE – A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC